How food affects a new drug: scientists test two tablet versions

NCT ID NCT07712640

Recruiting now Knowledge-focused Sponsor: BeOne Medicines Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests two different tablet versions of an experimental drug called BGB-58067 in healthy adults aged 18 to 65. The goal is to see how the body absorbs and processes each version, and whether taking the drug with food changes its effects. Participants receive a single dose of each tablet formulation in a random order, with blood samples taken to measure drug levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BGB-58067 tablets (two different formulations)
What this could lead to: If successful, this study will help determine the best tablet formulation and dosing conditions for BGB-58067, supporting future trials.
What could go wrong: This is an early-phase study in a small number of healthy volunteers, so results may not predict effects in patients or guarantee the drug's success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Cmax Clinical Research
RECRUITING

Adelaide, South Australia, SA 5000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.